These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35172420)

  • 1. Pharmacist-directed Sputnik V (GAM-COVID-VAC) surveillance program: a prospective observational study in Southern India.
    Karattuthodi MS; Chandrasekher D; Panakkal LM; C S; Salman M; Megha ; E MS; Fasil M; A M M; Reji M
    J Basic Clin Physiol Pharmacol; 2023 Jul; 34(4):509-517. PubMed ID: 35172420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance.
    Montalti M; Soldà G; Di Valerio Z; Salussolia A; Lenzi J; Forcellini M; Barvas E; Guttmann S; Messina R; Poluzzi E; Raschi E; Riccardi R; Fantini MP; La Fauci G; Gori D;
    EClinicalMedicine; 2021 Aug; 38():101027. PubMed ID: 34505029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance.
    Di Valerio Z; La Fauci G; Soldà G; Montalti M; Lenzi J; Forcellini M; Barvas E; Guttmann S; Poluzzi E; Raschi E; Riccardi R; Fantini MP; Salussolia A; Gori D
    EClinicalMedicine; 2022 Jul; 49():101468. PubMed ID: 35614901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gam-COVID-Vac (Sputnik V) and Pfizer-BioNTech Vaccines Adverse Events following Immunization in Patients Affected by Parkinson's Disease and Multiple Sclerosis: A Longitudinal Study.
    Soldà G; Barvas E; Lenzi J; Di Valerio Z; La Fauci G; Guttmann S; Riccardi R; Fantini MP; Salussolia A; Montalti M; Gori D
    Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35335001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning.
    Jarynowski A; Semenov A; Kamiński M; Belik V
    J Med Internet Res; 2021 Nov; 23(11):e30529. PubMed ID: 34662291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events following immunisation with the first dose of sputnik V among Iranian health care providers.
    Jafarzadeh Esfehani R; Zahmatkesh M; Goldozian R; Farkhonde J; Jaripour E; Hatami A; Bidkhori HR; Shamsian SK; Shamsian SA; Mojahedi F
    Clin Exp Vaccine Res; 2023 Jan; 12(1):25-31. PubMed ID: 36844688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study.
    Zeitoun A; Hallit S; Chehade S; Ibrahim A; Helali M; Allam C; Karam R
    J Pharm Policy Pract; 2023 Feb; 16(1):24. PubMed ID: 36810279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active surveillance of adverse events following immunization (AEFI): a prospective 3-year vaccine safety study.
    Sebastian J; Gurumurthy P; Ravi MD; Ramesh M
    Ther Adv Vaccines Immunother; 2019; 7():2515135519889000. PubMed ID: 31799496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of Antibody Response to Repeated Vaccination with Sputnik V: A Pilot Study with a Series of Five Cases.
    Boshku AA; Aleksovski V; Tofoski G; Spasova R
    EJIFCC; 2022 Aug; 33(2):175-186. PubMed ID: 36313912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of adverse events following immunization with measles rubella vaccine at a tertiary care hospital in East Delhi, India.
    Bhowmik E; Singh A; Sachan R
    Ther Adv Vaccines Immunother; 2020; 8():2515135520940131. PubMed ID: 32685913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Events Following COVID-19 Vaccination in Selected Apartments in Bangalore, India.
    Chakraborty A; Reval N; Kamath L
    Cureus; 2022 Feb; 14(2):e21809. PubMed ID: 35291520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran.
    Babamahmoodi F; Saeedi M; Alizadeh-Navaei R; Hedayatizadeh-Omran A; Mousavi SA; Ovaise G; Kordi S; Akbari Z; Azordeh M; Ahangarkani F; Alikhani A
    Sci Rep; 2021 Nov; 11(1):21464. PubMed ID: 34728696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India.
    Kamble B; Bashar MA; Mishra CP
    Cureus; 2022 Feb; 14(2):e21848. PubMed ID: 35273834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina.
    González S; Olszevicki S; Salazar M; Calabria A; Regairaz L; Marín L; Campos P; Varela T; Martínez VVG; Ceriani L; Garcia E; Kreplak N; Pifano M; Estenssoro E; Marsico F
    EClinicalMedicine; 2021 Oct; 40():101126. PubMed ID: 34541480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events following COVID-19 vaccination: first 90 days of experience from a tertiary care teaching hospital in South India.
    Basavaraja CK; Sebastian J; Ravi MD; John SB
    Ther Adv Vaccines Immunother; 2021; 9():25151355211055833. PubMed ID: 34841193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
    Jeon M; Kim J; Oh CE; Lee JY
    J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine.
    Ameri M; Abolmaali M; Alwedaie SMJ; Nabavi M; Rahimian N; Hamidabad NM
    Eur J Case Rep Intern Med; 2022; 9(1):003042. PubMed ID: 35169571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina.
    Chahla RE; Tomas-Grau RH; Cazorla SI; Ploper D; Vera Pingitore E; López MA; Aznar P; Alcorta ME; Vélez EMDM; Stagnetto A; Ávila CL; Maldonado-Galdeano C; Socias SB; Heinze D; Navarro SA; Llapur CJ; Costa D; Flores I; Edelstein A; Kowdle S; Perandones C; Lee B; Apfelbaum G; Mostoslavsky R; Mostoslavsky G; Perdigón G; Chehín RN
    Lancet Reg Health Am; 2022 Feb; 6():100123. PubMed ID: 34841388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students-which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?
    Houshmand B; Keyhan SO; Fallahi HR; Ramezanzade S; Sadeghi E; Yousefi P
    Maxillofac Plast Reconstr Surg; 2022 Jan; 44(1):3. PubMed ID: 35025010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term Side Effects of COVID-19 Vaccines (Astrazeneca, Sputnik-V, and Sinopharm) in Health Care Workers: A Cross-Sectional Study in Iran.
    Azimi-Nezhad M; Gholami A; Taghiabadi E; Ghodsi H
    Med J Islam Repub Iran; 2022; 36():159. PubMed ID: 36721491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.